Rasmussen’s syndrome treated with anakinra

Targeting Inflammatory Mediators in Epilepsy: A Systematic Review of Its Molecular Basis and Clinical Applications

(2022) Giorgio Costagliola et al.   Frontiers in Neurology

Towards a Treatment for Neuroinflammation in Epilepsy: Interleukin-1 Receptor Antagonist, Anakinra, as a Potential Treatment in Intractable Epilepsy

(2021) Gaku Yamanaka et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Anakinra usage in febrile infection related epilepsy syndrome: an international cohort

(2020) Yi‐Chen Lai et al.   Annals of Clinical and Translational Neurology

Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy

(2019) Annamaria Vezzani et al.   Nature Reviews Neurology

Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances

(2014) Sophia Varadkar et al.   LANCET NEUROLOGY

Evolution of the EEG in children with Rasmussen’s syndrome

(2012) Francesca Longaretti et al.   EPILEPSIA

IL-1β is induced in reactive astrocytes in the somatosensory cortex of rats with genetic absence epilepsy at the onset of spike-and-wave discharges, and contributes to their occurrence

(2011) Demet Akin et al.   NEUROBIOLOGY OF DISEASE